Coagulation studies in rheumatic heart disease. 1980

J L Toy, and D A Lederer, and A T Tulpule, and A P Tandon, and S H Taylor, and G P McNicol

The clotting characteristics of pulmonary and systemic blood were studied in 10 patients with chronic rheumatic mitral valve disease complicated by atrial fibrillation and in seven patients with aortic valve disease in sinus rhythm. A haemostatic basis for the association of rheumatic mitral valve disease with thrombotic emboli was sought. Both groups of patients showed differences in platelet function between pulmonary and systemic arterial blood. In patients with mitral valve disease aggregation of platelets was significantly greater in pulmonary than in systemic arterial blood at rest; the converse was true during exercise. In aortic valve disease platelet aggregation was greater in systemic than in pulmonary arterial blood at all times. Only the patients with mitral valve disease showed changes in blood coagulation during passage through the lungs and left heart; there was a small but statistically significant shortening in partial thromboplastin time in systemic as compared with pulmonary arterial blood both at rest and during exercise. Similarly, the effects of exercise on the various haemostatic factors measured were largely confined to the patients with mitral valve disease; in these patients exercise stimulated an increase in factor VIII in pulmonary arterial blood and an increase in platelet adhesiveness and aggregability in left heart blood. These changes provide a basis for the suggestion that in patients with rheumatic mitral valve disease, unlike those with aortic valve disease, there is an increased thrombotic tendency in blood in the left heart which is particularly pronounced during exercise.

UI MeSH Term Description Entries
D008297 Male Males
D008943 Mitral Valve The valve between the left atrium and left ventricle of the heart. Bicuspid Valve,Bicuspid Valves,Mitral Valves,Valve, Bicuspid,Valve, Mitral,Valves, Bicuspid,Valves, Mitral
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D010973 Platelet Adhesiveness The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces. Adhesiveness, Platelet,Adhesivenesses, Platelet,Platelet Adhesivenesses
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005260 Female Females
D006349 Heart Valve Diseases Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE). Heart Valvular Disease,Valvular Heart Diseases,Disease, Heart Valvular,Heart Disease, Valvular,Heart Valve Disease,Heart Valvular Diseases,Valve Disease, Heart,Valvular Disease, Heart,Valvular Heart Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J L Toy, and D A Lederer, and A T Tulpule, and A P Tandon, and S H Taylor, and G P McNicol
January 1978, Human heredity,
J L Toy, and D A Lederer, and A T Tulpule, and A P Tandon, and S H Taylor, and G P McNicol
November 1952, Circulation,
J L Toy, and D A Lederer, and A T Tulpule, and A P Tandon, and S H Taylor, and G P McNicol
August 1968, Lancet (London, England),
J L Toy, and D A Lederer, and A T Tulpule, and A P Tandon, and S H Taylor, and G P McNicol
January 1996, Vestnik Rossiiskoi akademii meditsinskikh nauk,
J L Toy, and D A Lederer, and A T Tulpule, and A P Tandon, and S H Taylor, and G P McNicol
January 1990, Indian journal of pediatrics,
J L Toy, and D A Lederer, and A T Tulpule, and A P Tandon, and S H Taylor, and G P McNicol
December 1973, The American journal of pathology,
J L Toy, and D A Lederer, and A T Tulpule, and A P Tandon, and S H Taylor, and G P McNicol
March 1984, Journal of clinical & laboratory immunology,
J L Toy, and D A Lederer, and A T Tulpule, and A P Tandon, and S H Taylor, and G P McNicol
January 1969, Indian heart journal,
J L Toy, and D A Lederer, and A T Tulpule, and A P Tandon, and S H Taylor, and G P McNicol
April 1965, Vrachebnoe delo,
J L Toy, and D A Lederer, and A T Tulpule, and A P Tandon, and S H Taylor, and G P McNicol
November 1971, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
Copied contents to your clipboard!